Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

A computer screen shows the user interface of mint Lesion™  on which the analytical evaluation of a scan can be seen

Brainlab and Mint Medical Enter Cooperation with the German Society for Orthopedics and Orthopedic Surgery

Today Mint Medical together with Brainlab entered into a cooperation with the German Society for Orthopedics and Orthopedic Surgery (DGOOC) and its non-profit subsidiary, RSG Register Solutions to develop a data protection-compliant registry infrastructure for patient data processing and thus strengthen medical research across healthcare institutions.

Mint Medical’s software is already being used in all 38 German university hospitals as part of the University Medicine Network RACOON project to record and categorize medical imaging and other data from Covid patients. Through the partnership with RSG, Mint Medical can now expand its registry offering and securely correlate patient data across hospitals and throughout patient treatment while maintaining strict data protection criteria.

Click here to read the full press release.

Related Resources

Related Resources

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…